Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

Anti-spike monoclonal antibody therapy may be effective for pregnant women with coronavirus disease 2019 (COVID-19).

Detalles Bibliográficos
Autores principales: Thilagar, Bright P., Ghosh, Aditya K., Nguyen, Jerome, Theiler, Regan N., Wick, Myra J., Hurt, Ryan T., Razonable, Raymund R., Ganesh, Ravindra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Contents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936149/
https://www.ncbi.nlm.nih.gov/pubmed/35026789
http://dx.doi.org/10.1097/AOG.0000000000004700
Descripción
Sumario:Anti-spike monoclonal antibody therapy may be effective for pregnant women with coronavirus disease 2019 (COVID-19).

Ejemplares similares